Ten Years After – Looking Back At A Biotech Boom...

Introduction There have historically been overlapping biotech booms and IPO windows, the three most recent boom/windows being 1995-1996, 1999-2001 and 2003-2005. Each of these boom/windows was impacted by positive external market forces, with the last two benefiting from the dot-com bubble and the post-9/11 market bounce, respectively. The driving factors within biotech have been different for each boom/window: 1995-1996 was...

New economic strategy team to be charged with deve...

Health and economic prosperity of Ontarians to flourish with vigorous, commercially viable life-sciences strategy TORONTO, June 9 – A new economic strategy team comprising representatives of major stakeholder groups in Ontario’s life-sciences sector will develop and direct a plan for robust growth and commercial viability of the province’s bioscience industry. The team, Ontario Bioscience Economic Strategy Team...

The Burrill Report – Canadian Edition, April...

Canada’s biotech stocks sizzled in the first quarter as they racked up impressive gains. The Burrill Canadian Biotech Index jumped 12 percent during the period. This is good news for the sector, which has languished for over three years. Low valuations have hampered the ability of public biotech companies to raise capital. The improving capital markets in Canada and the United States have helped bolster Toronto’s main...